alloxan has been researched along with 1,7-phenanthroline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boschero, AC; de Lúcio, MA; Eizirik, DL; Hoffmann, ME | 1 |
| Imada, M; Inoue, S; Kawanishi, S; Murata, M | 1 |
2 other study(ies) available for alloxan and 1,7-phenanthroline
| Article | Year |
|---|---|
1,10 phenanthroline, a metal chelator, protects against alloxan- but not streptozotocin-induced diabetes.
Topics: Alloxan; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Hydroxides; Hydroxyl Radical; Iron Chelating Agents; Male; Methylurea Compounds; Phenanthrolines; Rats; Rats, Inbred Strains; Streptozocin | 1986 |
Metal-mediated DNA damage induced by diabetogenic alloxan in the presence of NADH.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Alloxan; Animals; Barbiturates; Catalase; Cattle; Chelating Agents; Copper; Cytosine; Deoxyguanosine; DNA; DNA Damage; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; NAD; Phenanthrolines; Spectrophotometry, Ultraviolet; Superoxides; Thymine | 1998 |